EUVIMEDEUVIMED entdecken
Open Access

High macrolides and fluoroquinolones resistance rate in Mycoplasma genitalium in southern Tenerife

C Mateo León, D García Martínez de Artola, B Pino-Calm

Revista Española de Quimioterapia · 2023

DOI: 10.37201/req/014.2023 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Española de Quimioterapia, 2023. Verfasst von C Mateo León und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cristian Mateo León. Servicio de Microbiología y Parasitología Hospital Universitario Nuestra Señora de Candelaria, Tenerife, Spain. cristianmateoleo…. Hauptthemen laut MEDLINE: Mycoplasma genitalium, Mycoplasma Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Mycoplasma genitalium (MG) is a recognized sexually transmitted pathogen. Increasing resistance to main lines of treatment (macrolides and quinolones) justifies a genetic study of mutations to improve cure rates. Material and methods. A total of 8,508 samples from April 2018 to July 2022 were processed using AllplexTM STI Essential Assay. In MG positive cases 23S rRNA V domain, gyrA and parC genes were studied. Mutations detected were checked to assess their clinical significance and medical records were reviewed to obtain demographic and treatment information.

Results

Resistance study was performed on 92 samples (65 men and 27 women). In relation to the genotypic study, 28 patients presented mutations to macrolides (30.43%). Most common was A2059G (18.48%). For quinolones, 5 patients (5.43%) had clinically relevant mutations in parC gene. Of note was a patient with G295 mutation in gyrA associated with G248T in parC. Thirty subjects underwent a test of cure (TOC). Azithromycin was the most common empirical regimen and moxifloxacin the main alternative.

Conclusions

High rate of resistance in our environment evidences the need for targeted therapy by genotypic study of macrolide resistance, supported by the detection of mutations in parC and gyrA to predict quinolones susceptibility and the use of TOC to evaluate treatment response

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycoplasma genitaliumMycoplasma InfectionsMaleHumansFemaleAnti-Bacterial AgentsFluoroquinolonesMacrolidesDrug Resistance, BacterialRNA, Ribosomal, 23SMutationPrevalence

Stichwörter der Autor:innen

Mycoplasma genitaliumfluoroquinolonesmacrolides

Substanzen

Anti-Bacterial AgentsFluoroquinolonesMacrolidesRNA, Ribosomal, 23S

Autor:innen und Institutionen

  • Cristian Mateo León. Servicio de Microbiología y Parasitología Hospital Universitario Nuestra Señora de Candelaria, Tenerife, Spain. cristianmateoleon@gmail.com.

Zitieren

APA

Mateo León, C., García Martínez de Artola, D., & Pino-Calm, B. (2023). High macrolides and fluoroquinolones resistance rate in Mycoplasma genitalium in southern Tenerife. Revista Española de Quimioterapia. https://doi.org/10.37201/req/014.2023

Vancouver

Mateo León C, García Martínez de Artola D, Pino-Calm B. High macrolides and fluoroquinolones resistance rate in Mycoplasma genitalium in southern Tenerife. Revista Española de Quimioterapia. 2023. doi:10.37201/req/014.2023

BibTeX
@article{MateoLen2023,
  author = {Mateo León, C and García Martínez de Artola, D and Pino-Calm, B},
  title = {High macrolides and fluoroquinolones resistance rate in Mycoplasma genitalium in southern Tenerife},
  journal = {Revista Española de Quimioterapia},
  year = {2023},
  doi = {10.37201/req/014.2023}
}
Kostenlos starten →